Illumina | ILMN - Equity Capital And Reserves



Illumina reported $2.26B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Agilent USD 6.37B 234M Jul/2025
Bio Techne USD 1.92B 99.22M Jun/2025
Bio-Rad Laboratories USD 7.13B 449.3M Jun/2025
Boston Scientific USD 22.21B 443M Mar/2025
Bruker USD 1.87B 33.9M Jun/2025
Charles River Laboratories USD 3.31B 119.03M Jun/2025
Danaher USD 52.33B 1.48B Jun/2025
Dentsply International USD 1.96B 50M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Exact Sciences USD 2.47B 72.51M Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Illumina USD 2.26B 110M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Laboratory Of America USD 8.47B 151M Jun/2025
Mettler Toledo International USD -258793000 76.81M Jun/2025
Myriad Genetics USD 704.9M 3.8M Mar/2025
Quest Diagnostics USD 7.23B 299M Jun/2025
Quidel USD 2.79B 204.5M Jun/2025
Repligen USD 1.99B 12.76M Mar/2025
Revvity USD 7.64B 29.74M Mar/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Standard Biotools USD 424.54M 47.18M Jun/2025
Thermo Fisher Scientific USD 49.36B 227M Mar/2025
Waters USD 2.16B 197.42M Jun/2025